NBIX (STOCKS)
Neurocrine Biosciences Inc
$161.000000
+1.240000 (+0.78%)
Prev close: $159.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kyle W. Gano
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16,046.77M
- Employees
- 1,800
- P/E (TTM)
- 24.52
- P/B (TTM)
- 4.71
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
14
Strong Buy
17
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$1.91 | $1.18 | +0.7329 | +62.26% |
|
Dec 2025 (Q4)
|
$1.48 | $1.92 | -0.4394 | -22.89% |
|
Sep 2025 (Q3)
|
$2.04 | $1.62 | +0.4223 | +26.11% |
|
Jun 2025 (Q2)
|
$1.06 | $0.99 | +0.0693 | +7.00% |
Financial Statements
| Revenues | $3.10B |
| Benefits Costs and Expenses | $2.16B |
| Cost Of Revenue | $56.70M |
| Costs And Expenses | $2.31B |
| Gross Profit | $3.05B |
| Nonoperating Income/Loss | $148.60M |
| Operating Expenses | $2.26B |
| Selling, General, and Administrative Expenses | $1.20B |
| Other Operating Expenses | $1.06B |
| Operating Income/Loss | $788.90M |
| Income/Loss From Continuing Operations After Tax | $668.60M |
| Income/Loss From Continuing Operations Before Tax | $937.50M |
| Income Tax Expense/Benefit | $268.90M |
| Net Income/Loss | $668.60M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $668.60M |
| Net Income/Loss Available To Common Stockholders, Basic | $668.60M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $6.71 |
| Diluted Earnings Per Share | $6.49 |
| Basic Average Shares | 299,100,000 |
| Diluted Average Shares | 307,400,000 |
| Assets | $4.91B |
| Current Assets | $2.44B |
| Inventory | $64.50M |
| Prepaid Expenses | $224.80M |
| Other Current Assets | $2.15B |
| Noncurrent Assets | $2.47B |
| Fixed Assets | $90.90M |
| Other Non-current Assets | $2.38B |
| Liabilities | $1.50B |
| Current Liabilities | $831.70M |
| Wages | $81.70M |
| Other Current Liabilities | $750.00M |
| Noncurrent Liabilities | $667.10M |
| Equity | $3.41B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.41B |
| Liabilities And Equity | $4.91B |
| Net Cash Flow From Operating Activities | $863.70M |
| Net Cash Flow From Operating Activities, Continuing | $863.70M |
| Net Cash Flow From Investing Activities | -$784.80M |
| Net Cash Flow From Investing Activities, Continuing | -$784.80M |
| Net Cash Flow From Financing Activities | -$6.50M |
| Net Cash Flow From Financing Activities, Continuing | -$6.50M |
| Net Cash Flow | $72.40M |
| Net Cash Flow, Continuing | $72.40M |
| Comprehensive Income/Loss | $660.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $660.00M |
| Other Comprehensive Income/Loss | -$8.60M |